Distalmotion

Distalmotion is a Swiss medical device company founded in 2012, originating from the Robotics Lab at the Swiss Federal Institute of Technology in Lausanne (EPFL). Based in Lausanne, the company has expanded from a small startup to a team of over 150 employees from more than 25 nationalities. Distalmotion aims to democratize access to robotic surgery by lowering operational barriers and establishing a new standard of care in minimally invasive procedures. The company's flagship product, DEXTER, is a robotic surgery system designed for versatile use in urology, gynecology, and general surgery. DEXTER is CE-marked and has received FDA De Novo authorization for inguinal hernia repair. It has been in clinical use since 2021 and is integrated into existing surgical workflows, targeting hospitals and surgical centers looking for cost-effective robotic solutions. Distalmotion collaborates with expert teaching centers and clinicians to enhance its technology, reflecting its commitment to innovation in surgical robotics.